Sionna Therapeutics (NASDAQ:SION) Trading 10.2% Higher – Here’s What Happened

Sionna Therapeutics, Inc. (NASDAQ:SION) shares were up 10.2% during trading on Tuesday . The stock traded as high as $16.56 and last traded at $16.42. Approximately 118,927 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 224,239 shares. The stock had previously closed at $14.90.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Guggenheim assumed coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating and a $45.00 target price on the stock. Stifel Nicolaus started coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating and a $32.00 target price on the stock. Finally, TD Cowen initiated coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating for the company.

Sionna Therapeutics Stock Down 0.1 %

Sionna Therapeutics Company Profile

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.